I B Kerr

1.8k citations
14 papers · 1.5k indexed · 1 hit paper · h-index 11
Topics
Genetic factors in colorectal cancer (5 papers)RNA modifications and cancer (2 papers)Peptidase Inhibition and Analysis (2 papers)

In The Last Decade

I B Kerr

14 papers receiving 1.5k citations

Hit Papers

p53 mutations in colorectal cancer.19902026200220141990250500750

Peers

I B Kerr
Comparison fields: 5 of 92
  • Oncology 942
  • Molecular Biology 674
  • Cancer Research 366
  • Pathology and Forensic Medicine 346
  • Surgery 218
Replace Gauri C. Bedi with:
Gauri C. Bedi United States
Ning T. Yeh United States
CS Potten United Kingdom
Quintin Pan United States
Kun-Tu Yeh Taiwan
Ajay Matta Canada
Jean‐Paul Brouillet France
Peter van der Riet United States
Xiaoshan Feng China
Robert Veve United States
I B Kerr relative to Gauri C. Bedi United States Gauri C. Bedi's profile →
Citations per field
00.5×1.5×1.8×
Gauri C. Bedi · 1×
Citations per year

Countries citing papers authored by I B Kerr

Since Specialization
Citations

This map shows the geographic impact of I B Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I B Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I B Kerr more than expected).

Fields of papers citing papers by I B Kerr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I B Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I B Kerr. The network helps show where I B Kerr may publish in the future.

Co-authorship network of co-authors of I B Kerr

This figure shows the co-authorship network connecting the top 25 collaborators of I B Kerr. A scholar is included among the top collaborators of I B Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I B Kerr. I B Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1
Interleukin-6 and related cytokines: effect on the acute phase reaction.
44
2 203
3 20
4
Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indication.
8
5
p53 mutations in colorectal cancer.breakdown →
895
6 9
7 30
8
Toxicity of oral N-methylformamide in three phase II trials: a report from the National Cancer Institute of Canada Clinical Trials Group.
10
9 29
10 28
11 22
12 52
13 153
14
[Experimental South American blastomycosis in the rat. Development of the experimental disease in animals infected with Yoshida sarcoma].
2

About I B Kerr

I B Kerr is a scholar working on Microbiology, Pathology and Forensic Medicine and Oncology, having authored 14 papers that have together received 1.5k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (5 papers), RNA modifications and cancer (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Oncology (942 citations), Cancer Research (366 citations) and Pathology and Forensic Medicine (346 citations). I B Kerr has collaborated with scholars based in United Kingdom, Switzerland and India. Frequent co-authors include David P. Lane, Andrew Rowan, Julian Gannon, Nanda R. Rodrigues, Walter F. Bodmer, Mark E. Smith, Demetrios�� Spandidos, Newell W. Johnson, Dhananjaya Saranath and Rekha G. Panchal. Their work appears in journals such as Proceedings of the National Academy of Sciences, Gut and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026